Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Pharmacokinetics, tissue distribution and excretion of recombinant human parathyroid hormone 1-84 in animals.

Bai H, Jing D, Jiang H, Yin S.

Cell Biochem Biophys. 2013 Jun;66(2):379-87. doi: 10.1007/s12013-012-9477-4.

PMID:
23314825
2.

Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.

Hu Z, Niu H, Yang X, Li H, Sang G, Li B.

Int J Pharm. 2006 Jul 24;317(2):144-54. Epub 2006 Mar 12.

PMID:
16621369
3.

Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.

Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.

Clin Ther. 2014 May;36(5):722-36. doi: 10.1016/j.clinthera.2014.04.001. Epub 2014 May 5.

4.

Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.

Uchida T, Aoyama K, Mori K, Usui T, Watanabe T, Takariki Y, Asahara N, Hirose M, Kimura T, Tateishi M, Higuchi S.

Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):403-10.

PMID:
9842984
5.

Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.

Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.

Arzneimittelforschung. 1993 Oct;43(10):1084-94.

PMID:
8267675
6.

Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteers.

Liu Y, Shi S, Wu J, Li Z, Zhou X, Zeng F.

Basic Clin Pharmacol Toxicol. 2012 Feb;110(2):154-61. doi: 10.1111/j.1742-7843.2011.00768.x. Epub 2011 Aug 18.

8.

Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers.

Schwietert HR, Groen EW, Sollie FA, Jonkman JH.

Clin Pharmacol Ther. 1997 Mar;61(3):360-76.

PMID:
9084461
9.

Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats.

Yoshioka E, Kato K, Shindo H, Mitsuoka C, Kitajima SI, Ogata H, Misaizu T.

Xenobiotica. 2007 Jan;37(1):74-90.

PMID:
17178635
10.

Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.

Cai Y, Zhang Z, Fan K, Zhang J, Shen W, Li M, Si D, Luo H, Zeng Y, Fu P, Liu C.

Regul Pept. 2012 Jan 10;173(1-3):74-81. doi: 10.1016/j.regpep.2011.09.008. Epub 2011 Oct 8.

PMID:
21985916
11.
13.

Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.

Tang-Liu DD, Richman JB, Lin P, Selim S.

Biopharm Drug Dispos. 1993 May;14(4):313-24.

PMID:
8499582
14.

Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.

Tachibana M, Tanaka M, Mitsugi K, Jin Y, Takaichi M, Okazaki O.

Arzneimittelforschung. 2004;54(12):898-905.

PMID:
15646375
15.
16.
19.

Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys.

Song HF, Liu XW, Zhang HN, Zhu BZ, Yuan SJ, Liu SY, Tang ZM.

Acta Pharmacol Sin. 2005 Jan;26(1):124-8.

20.
Items per page

Supplemental Content

Write to the Help Desk